The post Analyst sets Oracle stock price target appeared on BitcoinEthereumNews.com. Oracle (NASDAQ: ORCL) is in the spotlight once again, its shares edging up The post Analyst sets Oracle stock price target appeared on BitcoinEthereumNews.com. Oracle (NASDAQ: ORCL) is in the spotlight once again, its shares edging up

Analyst sets Oracle stock price target

Oracle (NASDAQ: ORCL) is in the spotlight once again, its shares edging up 2.3% in pre-market on Wednesday, February 25, driven by a new price target from Wall Street.

Namely, Oppenheimer analyst Brian Schwartz has upgraded his ORCL stock rating to ‘Buy,’ with a price target of $185 for the next twelve months, implying a more than 25% upside from the last close at around $146.

However, Schwartz noted that the call may still be early, given that Oracle will need some time to show how financially successful its capital-intensive business is going to be.

Oppenheimer nonetheless believes the risk-reward profile has turned attractive, noting that the stock’s valuation multiples have been slashed by more than 50% since September.

As investors eagerly await the tech company’s next earnings report scheduled for March 9, the analyst argues that Oracle is a strong AI winner, as sentiment shifts and amid mitigating risks. 

Oracle stock outlook

While Oracle shares are up more than 2% in pre-market trading at press time, the stock is down roughly 25% in 2026, extending a steep selloff that began in late 2025. The decline has been driven largely by investor concerns over the company’s aggressive spending on artificial intelligence (AI) and cloud infrastructure.

Schwartz still views Oracle as a “strong EPS compounder,” though, noting that his base-case scenario applies a 25% haircut to management’s revenue guidance yet still calls for earnings to double by fiscal 2030.

In the analysis, Oppenheimer projected Oracle’s pro-forma earnings per share could grow at a 20% CAGR through fiscal 2023 in its base case, reaching $12.66. In a bull-case scenario, EPS would compound at roughly 30% annually to $17.79.

The note cited several factors supporting the optimism, including easing counterparty, financing, and execution risks following recent capital-raising initiatives and major customer wins such as OpenAI. 

Still, the analyst acknowledged that investor skepticism is understandable, pointing to concerns about balance sheet strain, margin pressure tied to AI investments, elevated counterparty risk, and the significant financing required to fund Oracle’s infrastructure expansion.

Featured image via Shutterstock

Source: https://finbold.com/analyst-sets-oracle-stock-price-target/

Market Opportunity
Overtake Logo
Overtake Price(TAKE)
$0.02043
$0.02043$0.02043
-0.87%
USD
Overtake (TAKE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags: